Regulatory interplay between microRNAs and WNT pathway in glioma - 09/10/21
pages | 18 |
Iconographies | 7 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Glioma is one of the most common neoplasms of the central nervous system with a poor survival. Due to the obstacles in treating this disease, a part of recent studies mainly focuses on identifying the underlying molecular mechanisms that contribute to its malignancy. Altering microRNAs (miRNAs) expression pattern has been identified obviously in many cancers. Through regulating various targets and signaling pathways, miRNAs play a pivotal role in cancer progression. As one of the essential signaling pathways, WNT pathway is dysregulated in many cancers, and a growing body of evidence emphasis its dysregulation in glioma. Herein, we provide a comprehensive review of miRNAs involved in WNT pathway in glioma. Moreover, we show the interplay between miRNAs and WNT pathway in regulating different processes such as proliferation, invasion, migration, radio/chemotherapy resistance, and epithelial-mesenchymal-transition. Then, we introduce several drugs and treatments against glioma, which their effects are mediated through the interplay of WNT pathway and miRNAs.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Aberrantly expressed miRNAs are implicated in WNT pathway dysregulation in glioma. |
• | This dysregulation contributes to therapy resistance and EMT in glioma cells. |
• | Circular and long non-coding RNAs can act as upstream regulators for these miRNAs. |
• | miRNAs involved in regulating AKT pathway can also affect WNT/β-catenin pathway. |
Keywords : miRNA, lncRNA, Glioma, WNT, circRNA
Plan
Vol 143
Article 112187- novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?